166 related articles for article (PubMed ID: 8876662)
1. Solubilization and characterization of binding sites for [3H]NE-100, a novel and potent sigma 1 ligand, from guinea pig brain.
Chaki S; Okuyama S; Ogawa S; Tanaka M; Muramatsu M; Nakazato A; Tomisawa K
Life Sci; 1996; 59(16):1331-40. PubMed ID: 8876662
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic characterization of binding sites for [3H]NE-100 in guinea pig brain.
Okuyama S; Chaki S; Yae T; Nakazato A; Muramatsu M
Life Sci; 1995; 57(21):PL333-7. PubMed ID: 7475936
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of binding of [3H]NE-100, a novel sigma-receptor ligand, to guinea-pig brain membranes.
Tanaka M; Shirasaki T; Kaku S; Muramatsu M; Otomo S
Naunyn Schmiedebergs Arch Pharmacol; 1995 Mar; 351(3):244-51. PubMed ID: 7609777
[TBL] [Abstract][Full Text] [Related]
4. NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain.
Chaki S; Tanaka M; Muramatsu M; Otomo S
Eur J Pharmacol; 1994 Jan; 251(1):R1-2. PubMed ID: 8137864
[TBL] [Abstract][Full Text] [Related]
5. The effect of prototypic sigma ligands on the binding of [3H]dextromethorphan to guinea pig brain.
Klein M; Paturzo JJ; Musacchio JM
Neurosci Lett; 1989 Feb; 97(1-2):175-80. PubMed ID: 2537477
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulation of ligand binding to [3H](+)pentazocine-defined sigma recognition sites by phenytoin.
DeHaven-Hudkins DL; Ford-Rice FY; Allen JT; Hudkins RL
Life Sci; 1993; 53(1):41-8. PubMed ID: 8515681
[TBL] [Abstract][Full Text] [Related]
7. Differences in the allosteric modulation by phenytoin of the binding properties of the sigma1 ligands [3H](+)-pentazocine and [3H]NE-100.
Cobos EJ; Lucena G; Baeyens JM; Del Pozo E
Synapse; 2006 Mar; 59(3):152-61. PubMed ID: 16342057
[TBL] [Abstract][Full Text] [Related]
8. Solubilization and characterization of sigma-receptors from guinea pig brain membranes.
Kavanaugh MP; Parker J; Bobker DH; Keana JF; Weber E
J Neurochem; 1989 Nov; 53(5):1575-80. PubMed ID: 2552016
[TBL] [Abstract][Full Text] [Related]
9. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
Karbon EW; Naper K; Pontecorvo MJ
Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain.
DeHaven-Hudkins DL; Fleissner LC; Ford-Rice FY
Eur J Pharmacol; 1992 Dec; 227(4):371-8. PubMed ID: 1359973
[TBL] [Abstract][Full Text] [Related]
11. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
12. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
[TBL] [Abstract][Full Text] [Related]
13. Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes.
McCann DJ; Su TP
J Pharmacol Exp Ther; 1991 May; 257(2):547-54. PubMed ID: 1851829
[TBL] [Abstract][Full Text] [Related]
14. Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding.
Yamamoto H; Miura R; Yamamoto T; Shinohara K; Watanabe M; Okuyama S; Nakazato A; Nukada T
FEBS Lett; 1999 Feb; 445(1):19-22. PubMed ID: 10069366
[TBL] [Abstract][Full Text] [Related]
15. [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain.
Bonhaus DW; Loury DN; Jakeman LB; Hsu SA; To ZP; Leung E; Zeitung KD; Eglen RM; Wong EH
J Pharmacol Exp Ther; 1994 Oct; 271(1):484-93. PubMed ID: 7965749
[TBL] [Abstract][Full Text] [Related]
16. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist.
Matsuno K; Nakazawa M; Okamoto K; Kawashima Y; Mita S
Eur J Pharmacol; 1996 Jun; 306(1-3):271-9. PubMed ID: 8813641
[TBL] [Abstract][Full Text] [Related]
17. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
Hellewell SB; Bowen WD
Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
[TBL] [Abstract][Full Text] [Related]
18. [3H]-(+)-pentazocine binding to sigma recognition sites in human cerebellum.
Zabetian CP; Staley JK; Flynn DD; Mash DC
Life Sci; 1994; 55(20):PL389-95. PubMed ID: 7968220
[TBL] [Abstract][Full Text] [Related]
19. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.
Nguyen VH; Kassiou M; Johnston GA; Christie MJ
Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604
[TBL] [Abstract][Full Text] [Related]
20. [3H](+)-pentazocine binding to rat brain sigma 1 receptors.
Cagnotto A; Bastone A; Mennini T
Eur J Pharmacol; 1994 Jan; 266(2):131-8. PubMed ID: 8157067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
